PRAZOSIN HYDROCHLORIDE

PRAZOSIN HYDROCHLORIDE was reported 1387 times

PRAZOSIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART FAILURE WITH PRESERVED EJECTION FRACTION 69 0.2347
1 CENTRAL NERVOUS SYSTEM LUPUS 40 0.1794
2 BODY MASS INDEX ABNORMAL 39 0.1598
3 SCROTAL CELLULITIS 5 0.0877
4 SEROSITIS 40 0.0723
5 TENDER JOINT COUNT INCREASED 5 0.0617
6 DOPAMINE TRANSPORTER SCINTIGRAPHY ABNORMAL 2 0.0606
7 NASAL FLARING 6 0.0444
8 CONGENITAL NAEVUS 6 0.0423
9 BLOOD ZINC INCREASED 1 0.0333
10 HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME 2 0.0286
11 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 6 0.0222
12 BLOOD PRESSURE AMBULATORY INCREASED 1 0.0217
13 LUPUS NEPHRITIS 40 0.0214
14 ADRENAL CARCINOMA 1 0.0213
15 ASPARTATE AMINOTRANSFERASE 5 0.0205
16 BLOOD AMYLASE DECREASED 1 0.0200
17 NEONATAL BEHAVIOURAL SYNDROME 6 0.0196
18 GLOBULINS INCREASED 7 0.0192
19 CARDIAC AUTONOMIC NEUROPATHY 1 0.0192
20 POST CHOLECYSTECTOMY SYNDROME 5 0.0177
21 POSITIVE AIRWAY PRESSURE THERAPY 5 0.0171
22 ACTIVATED PARTIAL THROMBOPLASTIN TIME 1 0.0164
23 VASCULAR ACCESS SITE COMPLICATION 4 0.0159
24 USE OF ACCESSORY RESPIRATORY MUSCLES 6 0.0145
25 CONSTRICTED AFFECT 1 0.0143
26 ALPHA 1 GLOBULIN INCREASED 1 0.0125
27 GRANULOCYTE COUNT INCREASED 5 0.0123
28 NARCOTIC INTOXICATION 3 0.0116
29 TRI-IODOTHYRONINE DECREASED 6 0.0115
30 CYST DRAINAGE 1 0.0104
31 VITAMIN B12 INCREASED 8 0.0100
32 THYROXINE DECREASED 6 0.0097
33 BAND NEUTROPHIL PERCENTAGE INCREASED 1 0.0096
34 BLOOD IMMUNOGLOBULIN A INCREASED 5 0.0093
35 VERY LOW DENSITY LIPOPROTEIN INCREASED 2 0.0090
36 KERATOSIS PILARIS 2 0.0080
37 ANAL FISTULA INFECTION 1 0.0067
38 INCREASED DOSE ADMINISTERED 2 0.0064
39 IMMUNE-MEDIATED NEPHRITIS 3 0.0064
40 NEONATAL RESPIRATORY DISTRESS 6 0.0064
41 PYELOCALIECTASIS 6 0.0063
42 GLOMERULAR FILTRATION RATE INCREASED 5 0.0061
43 ELECTRIC SHOCK 5 0.0058
44 SYSTOLIC DYSFUNCTION 6 0.0057
45 TROPONIN T INCREASED 7 0.0055
46 LEFT ATRIAL DILATATION 7 0.0055
47 CORNEAL REFLEX DECREASED 2 0.0053
48 BLOOD INSULIN ABNORMAL 1 0.0053
49 MOANING 6 0.0053
50 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
51 DACTYLITIS 5 0.0051
52 MATERNAL EXPOSURE TIMING UNSPECIFIED 19 0.0051
53 BURN INFECTION 1 0.0049
54 RHEUMATOID FACTOR INCREASED 5 0.0045
55 BLOOD MAGNESIUM INCREASED 4 0.0044
56 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
57 ECHOCARDIOGRAM ABNORMAL 6 0.0043
58 BASEDOW'S DISEASE 2 0.0043
59 BODY HEIGHT INCREASED 2 0.0041
60 BURNING FEET SYNDROME 1 0.0040
61 HYPOGLYCAEMIA NEONATAL 6 0.0037
62 PILOERECTION 4 0.0037
63 FLASHBACK 2 0.0035
64 BACTERIAL VULVOVAGINITIS 1 0.0035
65 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1 0.0034
66 NERVE BLOCK 2 0.0034
67 ASPARTATE AMINOTRANSFERASE ABNORMAL 5 0.0033
68 C-REACTIVE PROTEIN DECREASED 2 0.0031
69 INFUSION SITE URTICARIA 2 0.0030
70 ALCOHOLIC LIVER DISEASE 1 0.0029
71 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
72 ANION GAP DECREASED 1 0.0029
73 NUTRITIONAL CONDITION ABNORMAL 2 0.0029
74 WHITE BLOOD CELLS URINE POSITIVE 5 0.0027
75 INTERVERTEBRAL DISCITIS 5 0.0026
76 ACCELERATED HYPERTENSION 1 0.0026
77 BASOPHIL COUNT INCREASED 2 0.0026
78 DILATATION ATRIAL 3 0.0026
79 JOINT NOISE 5 0.0025
80 CATHETER SITE EXTRAVASATION 1 0.0025
81 MONOCYTE COUNT INCREASED 9 0.0025
82 POST-ACUTE COVID-19 SYNDROME 3 0.0024
83 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
84 PROCEDURAL HYPOTENSION 2 0.0024
85 GOUT 41 0.0023
86 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
87 ALLERGY TO ARTHROPOD STING 1 0.0022
88 VASOSPASM 2 0.0022
89 BEZOAR 3 0.0022
90 BODY TEMPERATURE ABNORMAL 4 0.0022
91 BILIARY SEPSIS 1 0.0022
92 WRIST SURGERY 2 0.0021
93 MAST CELL ACTIVATION SYNDROME 3 0.0021
94 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
95 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
96 PRIAPISM 7 0.0020
97 BLADDER MASS 1 0.0020
98 FOAMING AT MOUTH 4 0.0020
99 BREAST CONSERVING SURGERY 1 0.0020
100 POST-TRAUMATIC STRESS DISORDER 13 0.0019
101 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
102 ABDOMINAL INJURY 1 0.0019
103 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
104 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
105 CARDIAC DYSFUNCTION 7 0.0019
106 BLOOD INSULIN INCREASED 1 0.0018
107 TINEA INFECTION 2 0.0018
108 BLOOD PH INCREASED 1 0.0018
109 ANXIETY DISORDER 6 0.0018
110 CATHETER SITE DISCHARGE 2 0.0018
111 CATHETER SITE INFLAMMATION 1 0.0018
112 HAEMATURIA 60 0.0018
113 INFUSION SITE DISCHARGE 3 0.0017
114 INCISION SITE PAIN 2 0.0017
115 AMBLYOPIA 1 0.0017
116 PNEUMONIA INFLUENZAL 2 0.0017
117 ADRENAL ADENOMA 1 0.0017
118 INFECTED CYST 2 0.0017
119 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
120 ESSENTIAL HYPERTENSION 3 0.0016
121 TOOTH EROSION 2 0.0016
122 PUPILLARY REFLEX IMPAIRED 3 0.0016
123 BLOOD BILIRUBIN DECREASED 1 0.0016
124 DIASTOLIC DYSFUNCTION 5 0.0016
125 HYPERKALAEMIA 55 0.0016
126 SWOLLEN JOINT COUNT INCREASED 5 0.0016
127 NOCARDIOSIS 4 0.0016
128 NEUTROPHIL COUNT INCREASED 16 0.0016
129 LYMPHOCYTE COUNT INCREASED 5 0.0015
130 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
131 BODY MASS INDEX INCREASED 2 0.0015
132 EYELID PAIN 3 0.0015
133 CLUSTER HEADACHE 2 0.0015
134 CUSHING'S SYNDROME 1 0.0014
135 HYPERVOLAEMIA 7 0.0014
136 BORDERLINE PERSONALITY DISORDER 1 0.0014
137 PORPHYRIA ACUTE 2 0.0014
138 BACTERIAL DISEASE CARRIER 1 0.0014
139 ARTERIAL INJURY 1 0.0013
140 THROAT CLEARING 5 0.0013
141 VASCULAR DEVICE INFECTION 6 0.0013
142 BRONCHITIS BACTERIAL 1 0.0013
143 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
144 ONYCHOLYSIS 2 0.0013
145 BACTERIAL VAGINOSIS 2 0.0013
146 CHRONIC ALLOGRAFT NEPHROPATHY 1 0.0013
147 VITAMIN B12 DEFICIENCY 5 0.0012
148 DEMYELINATION 5 0.0012
149 INFUSION SITE HAEMORRHAGE 4 0.0012
150 BLOOD URIC ACID INCREASED 7 0.0012
151 DEVICE INFUSION ISSUE 3 0.0012
152 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
153 BRADYCARDIA FOETAL 1 0.0012
154 CRANIOFACIAL FRACTURE 1 0.0012
155 AREFLEXIA 3 0.0011
156 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
157 HAEMOGLOBIN INCREASED 5 0.0011
158 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
159 SYNOVIAL CYST 5 0.0011
160 ADVERSE FOOD REACTION 1 0.0011
161 BLOOD UREA INCREASED 18 0.0011
162 CATHETER SITE SWELLING 1 0.0011
163 BONE CYST 1 0.0011
164 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
165 NARCOLEPSY 2 0.0011
166 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
167 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
168 KIDNEY TRANSPLANT REJECTION 5 0.0010
169 BLOOD ALBUMIN DECREASED 8 0.0010
170 OBSTRUCTION 4 0.0010
171 CENTRAL VENOUS CATHETERISATION 3 0.0010
172 AUTONOMIC NEUROPATHY 1 0.0010
173 HYPERURICAEMIA 4 0.0010
174 BLADDER DYSFUNCTION 1 0.0010
175 TONGUE BITING 2 0.0010
176 CARPAL TUNNEL DECOMPRESSION 1 0.0009
177 EYE CONTUSION 2 0.0009
178 SLEEP DEFICIT 2 0.0009
179 BONE DEMINERALISATION 1 0.0009
180 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
181 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
182 SUBSTANCE USE DISORDER 3 0.0009
183 INFUSION SITE PAIN 12 0.0009
184 BONE NEOPLASM 1 0.0009
185 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
186 INSURANCE ISSUE 14 0.0009
187 ACINETOBACTER INFECTION 1 0.0009
188 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
189 IMPAIRED QUALITY OF LIFE 13 0.0009
190 DEMENTIA WITH LEWY BODIES 1 0.0009
191 STREPTOCOCCAL INFECTION 5 0.0009
192 CARDIAC HYPERTROPHY 1 0.0009
193 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
194 CHOLECYSTITIS ACUTE 5 0.0009
195 PREMATURE DELIVERY 14 0.0009
196 RESPIRATION ABNORMAL 6 0.0009
197 CYTOMEGALOVIRUS COLITIS 2 0.0009
198 ADMINISTRATION SITE PAIN 1 0.0009
199 HYPERTRANSAMINASAEMIA 6 0.0009
200 RENAL IMPAIRMENT 72 0.0009
201 BRONCHIAL HYPERREACTIVITY 1 0.0008
202 INFUSION SITE ERYTHEMA 7 0.0008
203 GANGRENE 5 0.0008
204 VITAMIN D DEFICIENCY 8 0.0008
205 BRONCHITIS CHRONIC 2 0.0008
206 MENISCUS INJURY 5 0.0008
207 BREATH SOUNDS ABNORMAL 4 0.0008
208 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
209 BLOOD UREA DECREASED 1 0.0008
210 AUTOIMMUNE THYROIDITIS 3 0.0008
211 BLOOD BILIRUBIN ABNORMAL 1 0.0008
212 BLOOD CHLORIDE DECREASED 2 0.0008
213 TEMPERATURE INTOLERANCE 8 0.0008
214 CATHETER SITE PAIN 2 0.0008
215 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
216 RESPIRATORY ACIDOSIS 3 0.0008
217 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
218 PRODUCT DISTRIBUTION ISSUE 7 0.0008
219 PROTEIN TOTAL INCREASED 2 0.0008
220 FOOD POISONING 4 0.0007
221 HEREDITARY ANGIOEDEMA 8 0.0007
222 ANAESTHETIC COMPLICATION 2 0.0007
223 ADRENAL INSUFFICIENCY 9 0.0007
224 SKIN DISCOMFORT 2 0.0007
225 CHONDROPATHY 2 0.0007
226 POISONING DELIBERATE 7 0.0007
227 CARBON DIOXIDE INCREASED 1 0.0007
228 AGORAPHOBIA 1 0.0007
229 SUBDURAL HAEMORRHAGE 2 0.0007
230 CHRONIC FATIGUE SYNDROME 1 0.0007
231 SLEEP TERROR 3 0.0007
232 CATAPLEXY 1 0.0007
233 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
234 AUDITORY DISORDER 1 0.0007
235 SINUS TACHYCARDIA 10 0.0007
236 PURULENT DISCHARGE 3 0.0007
237 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
238 PARAPLEGIA 2 0.0007
239 NEGATIVE THOUGHTS 2 0.0007
240 DECREASED INTEREST 4 0.0007
241 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
242 URINE ANALYSIS ABNORMAL 2 0.0007
243 LUNG ADENOCARCINOMA 2 0.0007
244 SUSPECTED OFF LABEL USE 3 0.0007
245 TENDON PAIN 5 0.0007
246 TROPONIN INCREASED 5 0.0007
247 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
248 ARTHRITIS INFECTIVE 3 0.0006
249 INFUSION SITE SWELLING 4 0.0006
250 HYPOVOLAEMIC SHOCK 3 0.0006
251 MIOSIS 5 0.0006
252 RHINITIS 5 0.0006
253 HYPERPROLACTINAEMIA 4 0.0006
254 COSTOCHONDRITIS 1 0.0006
255 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
256 COLONIC POLYP 1 0.0006
257 ARTHROPOD STING 1 0.0006
258 PRODUCT DOSE OMISSION IN ERROR 17 0.0006
259 LYME DISEASE 2 0.0006
260 THERAPEUTIC AGENT TOXICITY 2 0.0006
261 POTENTIATING DRUG INTERACTION 2 0.0006
262 INITIAL INSOMNIA 6 0.0006
263 WOUND COMPLICATION 2 0.0006
264 HEPATIC FIBROSIS 2 0.0006
265 CERVICAL SPINAL STENOSIS 1 0.0006
266 BLOOD CHLORIDE INCREASED 1 0.0006
267 GRANULOMA 2 0.0006
268 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
269 SEASONAL ALLERGY 8 0.0006
270 BREAST CYST 1 0.0006
271 PHARYNGITIS STREPTOCOCCAL 6 0.0006
272 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
273 PSYCHIATRIC SYMPTOM 4 0.0005
274 INTRACRANIAL PRESSURE INCREASED 3 0.0005
275 TENDON INJURY 2 0.0005
276 BLOOD CHOLESTEROL DECREASED 1 0.0005
277 PREMATURE BABY 16 0.0005
278 SNORING 2 0.0005
279 SPINAL DISORDER 5 0.0005
280 IMPAIRED GASTRIC EMPTYING 7 0.0005
281 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
282 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
283 HYPERPHAGIA 2 0.0005
284 AZOTAEMIA 2 0.0005
285 INTRACRANIAL ANEURYSM 2 0.0005
286 CORONARY ARTERY THROMBOSIS 1 0.0005
287 RED BLOOD CELL COUNT DECREASED 14 0.0005
288 COMPULSIVE SHOPPING 1 0.0005
289 PIGMENTATION DISORDER 3 0.0005
290 PRE-EXISTING CONDITION IMPROVED 3 0.0005
291 DRUG USE DISORDER 4 0.0005
292 ALCOHOLISM 2 0.0005
293 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
294 MUSCLE STRAIN 4 0.0005
295 ANGINA UNSTABLE 3 0.0005
296 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
297 BLOOD PRESSURE FLUCTUATION 11 0.0005
298 URINE OUTPUT DECREASED 4 0.0005
299 ASPIRATION 5 0.0005
300 BIPOLAR I DISORDER 1 0.0005
301 WALKING AID USER 3 0.0005
302 ABDOMINAL PAIN 105 0.0005
303 BACTERIAL TEST POSITIVE 1 0.0004
304 CALCINOSIS 1 0.0004
305 URINARY TRACT DISORDER 2 0.0004
306 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
307 ULCER 7 0.0004
308 RESPIRATORY ARREST 12 0.0004
309 LOCALISED OEDEMA 2 0.0004
310 BACK DISORDER 7 0.0004
311 PERFORMANCE STATUS DECREASED 2 0.0004
312 BILIRUBIN CONJUGATED INCREASED 1 0.0004
313 BLOOD PROLACTIN INCREASED 2 0.0004
314 COLORECTAL CANCER METASTATIC 1 0.0004
315 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
316 PRODUCT SUPPLY ISSUE 3 0.0004
317 CARDIOGENIC SHOCK 6 0.0004
318 MAJOR DEPRESSION 3 0.0004
319 INCORRECT DOSAGE ADMINISTERED 2 0.0004
320 PHARYNGEAL SWELLING 4 0.0004
321 SMALL INTESTINAL OBSTRUCTION 5 0.0004
322 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
323 FOOT OPERATION 2 0.0004
324 LYMPHOCYTE COUNT DECREASED 7 0.0004
325 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
326 WEIGHT LOSS POOR 2 0.0004
327 FOOD ALLERGY 3 0.0004
328 VARICOSE VEIN 2 0.0004
329 COMPARTMENT SYNDROME 1 0.0004
330 MULTIPLE ALLERGIES 3 0.0004
331 WEIGHT FLUCTUATION 4 0.0004
332 RESPIRATORY TRACT CONGESTION 6 0.0004
333 ALCOHOL ABUSE 1 0.0004
334 ALCOHOL POISONING 1 0.0004
335 PRESYNCOPE 9 0.0004
336 SINUS CONGESTION 5 0.0004
337 FRACTURE 7 0.0004
338 BLOOD POTASSIUM INCREASED 6 0.0004
339 BLOOD PHOSPHORUS INCREASED 1 0.0004
340 CLONUS 1 0.0004
341 NONSPECIFIC REACTION 2 0.0004
342 HYPERKERATOSIS 2 0.0004
343 COMPLETED SUICIDE 30 0.0004
344 MATERNAL EXPOSURE DURING PREGNANCY 32 0.0004
345 COORDINATION ABNORMAL 5 0.0004
346 KIDNEY INFECTION 7 0.0004
347 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
348 BLOOD TEST ABNORMAL 5 0.0004
349 PRODUCT DOSE OMISSION ISSUE 104 0.0004
350 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
351 BLOOD PRESSURE ABNORMAL 7 0.0004
352 CARDIAC VALVE DISEASE 2 0.0003
353 MYOCARDITIS 4 0.0003
354 HEAD INJURY 11 0.0003
355 SEIZURE 40 0.0003
356 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
357 COLD SWEAT 6 0.0003
358 ILLNESS 35 0.0003
359 CARDIOMYOPATHY 5 0.0003
360 EAR INFECTION 9 0.0003
361 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
362 FACIAL PAIN 3 0.0003
363 CARDIAC PACEMAKER INSERTION 2 0.0003
364 PROTHROMBIN TIME PROLONGED 2 0.0003
365 HEPATITIS B 2 0.0003
366 CEREBROVASCULAR DISORDER 1 0.0003
367 RENAL FAILURE ACUTE 14 0.0003
368 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
369 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
370 POOR QUALITY SLEEP 7 0.0003
371 BRAIN DEATH 1 0.0003
372 PRODUCT PRESCRIBING ISSUE 7 0.0003
373 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
374 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
375 FLANK PAIN 3 0.0003
376 HEPATIC CIRRHOSIS 6 0.0003
377 BRAIN FOG 5 0.0003
378 PHOTOPSIA 2 0.0003
379 RECALLED PRODUCT ADMINISTERED 3 0.0003
380 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
381 MYDRIASIS 4 0.0003
382 HYPOTENSION 62 0.0003
383 AUTOIMMUNE DISORDER 3 0.0003
384 RESPIRATORY TRACT INFECTION 8 0.0003
385 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
386 COELIAC DISEASE 3 0.0003
387 VITREOUS FLOATERS 3 0.0003
388 DEAFNESS NEUROSENSORY 1 0.0003
389 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
390 FACE OEDEMA 5 0.0003
391 TOOTH ABSCESS 3 0.0003
392 SLUGGISHNESS 3 0.0003
393 BLOOD TESTOSTERONE DECREASED 2 0.0003
394 EYE MOVEMENT DISORDER 2 0.0003
395 POOR VENOUS ACCESS 3 0.0003
396 NIGHTMARE 10 0.0003
397 LARGE INTESTINE POLYP 2 0.0003
398 ORTHOSTATIC HYPOTENSION 5 0.0003
399 OXYGEN SATURATION DECREASED 16 0.0003
400 INCONTINENCE 3 0.0003
401 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
402 THERMAL BURN 2 0.0003
403 INTENTIONAL DOSE OMISSION 8 0.0003
404 FEAR OF INJECTION 2 0.0003
405 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
406 GASTROENTERITIS VIRAL 5 0.0003
407 PULMONARY THROMBOSIS 3 0.0003
408 CUTANEOUS VASCULITIS 1 0.0003
409 SUICIDAL IDEATION 25 0.0003
410 DENTAL CARIES 3 0.0003
411 ALCOHOL USE 1 0.0003
412 HYPOPHOSPHATAEMIA 2 0.0003
413 OCULAR DISCOMFORT 3 0.0003
414 HYDRONEPHROSIS 2 0.0003
415 BLOOD SODIUM DECREASED 5 0.0003
416 CATHETER SITE INFECTION 1 0.0003
417 FOOT FRACTURE 5 0.0003
418 MICTURITION URGENCY 3 0.0003
419 COMMUNICATION DISORDER 1 0.0003
420 DISSOCIATION 2 0.0003
421 GASTRIC HAEMORRHAGE 3 0.0003
422 RENAL FAILURE CHRONIC 2 0.0003
423 PERICARDIAL EFFUSION 6 0.0003
424 MUSCULOSKELETAL CHEST PAIN 4 0.0003
425 ANKLE FRACTURE 4 0.0003
426 CONCUSSION 2 0.0003
427 HYPOALBUMINAEMIA 2 0.0003
428 ASTHMA 29 0.0003
429 SKIN FISSURES 5 0.0003
430 DRUG SCREEN POSITIVE 2 0.0003
431 MENTAL DISORDER 11 0.0003
432 HAEMATOCRIT DECREASED 5 0.0003
433 HALLUCINATION, AUDITORY 4 0.0003
434 MYOCLONUS 3 0.0003
435 PRODUCTIVE COUGH 12 0.0003
436 THROMBOCYTOPENIA 28 0.0003
437 SYNCOPE 25 0.0002
438 ARTERIOSPASM CORONARY 1 0.0002
439 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
440 MYASTHENIA GRAVIS 2 0.0002
441 NOCTURIA 3 0.0002
442 NEURALGIA 6 0.0002
443 FEEDING DISORDER 5 0.0002
444 TASTE DISORDER 5 0.0002
445 POST PROCEDURAL INFECTION 2 0.0002
446 RESTLESSNESS 9 0.0002
447 SUBSTANCE ABUSE 2 0.0002
448 SHOCK HAEMORRHAGIC 2 0.0002
449 COVID-19 43 0.0002
450 CYTOPENIA 3 0.0002
451 ABNORMAL FAECES 2 0.0002
452 SINUSITIS 25 0.0002
453 ARTHRITIS BACTERIAL 1 0.0002
454 AORTIC DISSECTION 1 0.0002
455 SLEEP DISORDER 17 0.0002
456 EOSINOPHIL COUNT INCREASED 2 0.0002
457 TYPE 2 DIABETES MELLITUS 8 0.0002
458 CANDIDA INFECTION 4 0.0002
459 BUNDLE BRANCH BLOCK LEFT 1 0.0002
460 HEPATIC CYTOLYSIS 3 0.0002
461 AORTIC VALVE INCOMPETENCE 1 0.0002
462 ABSCESS LIMB 1 0.0002
463 CARDIAC FAILURE CHRONIC 1 0.0002
464 RETCHING 5 0.0002
465 ANURIA 2 0.0002
466 DIPLOPIA 6 0.0002
467 COMA 11 0.0002
468 INFLUENZA LIKE ILLNESS 19 0.0002
469 SKIN SWELLING 2 0.0002
470 EYE PAIN 13 0.0002
471 BRONCHITIS 17 0.0002
472 NAIL DISORDER 2 0.0002
473 DERMATITIS ATOPIC 12 0.0002
474 TOOTH INFECTION 3 0.0002
475 BLOOD CREATINE INCREASED 1 0.0002
476 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
477 CATHETERISATION CARDIAC 1 0.0002
478 EXPOSURE DURING PREGNANCY 14 0.0002
479 HAEMARTHROSIS 2 0.0002
480 GASTROINTESTINAL INFECTION 2 0.0002
481 MYOSITIS 2 0.0002
482 ANAL INCONTINENCE 2 0.0002
483 TOOTHACHE 4 0.0002
484 CRYING 8 0.0002
485 C-REACTIVE PROTEIN INCREASED 8 0.0002
486 HIDRADENITIS 2 0.0002
487 ABDOMINAL HERNIA 1 0.0002
488 BRAIN NEOPLASM 2 0.0002
489 INCREASED TENDENCY TO BRUISE 2 0.0002
490 IRON DEFICIENCY ANAEMIA 2 0.0002
491 HYPOKALAEMIA 10 0.0002
492 BLOOD GLUCOSE ABNORMAL 4 0.0002
493 BLOOD CHOLESTEROL INCREASED 10 0.0002
494 PERIPHERAL SWELLING 33 0.0002
495 MIDDLE INSOMNIA 4 0.0002
496 PHOTOPHOBIA 4 0.0002
497 ARTERIOSCLEROSIS 2 0.0002
498 BLOOD PRESSURE DECREASED 14 0.0002
499 FUNGAL INFECTION 7 0.0002
500 THERAPY INTERRUPTED 15 0.0002
501 SLEEP APNOEA SYNDROME 4 0.0002
502 CHOLESTASIS 4 0.0002
503 SEROTONIN SYNDROME 4 0.0002
504 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
505 SINUS BRADYCARDIA 2 0.0002
506 DEPRESSION 47 0.0002
507 THROMBOTIC MICROANGIOPATHY 2 0.0002
508 HAEMORRHOIDS 4 0.0002
509 DISTURBANCE IN ATTENTION 11 0.0002
510 LOSS OF CONSCIOUSNESS 26 0.0002
511 SKIN HAEMORRHAGE 3 0.0002
512 LIGAMENT SPRAIN 2 0.0002
513 BLADDER DISORDER 2 0.0002
514 PULMONARY MASS 3 0.0002
515 INABILITY TO AFFORD MEDICATION 2 0.0002
516 ANEURYSM 1 0.0002
517 HYPOTONIA 2 0.0002
518 OVARIAN CYST 2 0.0002
519 MYALGIA 34 0.0002
520 BLOOD POTASSIUM DECREASED 6 0.0002
521 CORONARY ARTERY STENOSIS 1 0.0002
522 ECONOMIC PROBLEM 3 0.0002
523 THERAPEUTIC RESPONSE DECREASED 12 0.0002
524 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
525 CONTUSION 19 0.0002
526 BALANCE DISORDER 17 0.0002
527 AMMONIA INCREASED 1 0.0002
528 EAR DISCOMFORT 2 0.0002
529 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
530 UNRESPONSIVE TO STIMULI 5 0.0002
531 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
532 COGNITIVE DISORDER 9 0.0002
533 TENDERNESS 2 0.0002
534 HALLUCINATION, VISUAL 4 0.0002
535 FULL BLOOD COUNT ABNORMAL 2 0.0002
536 OSTEOARTHRITIS 8 0.0002
537 CYSTITIS 6 0.0002
538 ANAL FISTULA 1 0.0002
539 BIPOLAR DISORDER 2 0.0002
540 SKIN LACERATION 2 0.0002
541 BACK INJURY 2 0.0002
542 BLOOD CREATININE INCREASED 12 0.0002
543 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
544 MULTIPLE FRACTURES 3 0.0002
545 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
546 ASTHENOPIA 1 0.0002
547 URINARY TRACT INFECTION 31 0.0002
548 TOOTH FRACTURE 2 0.0002
549 ABNORMAL DREAMS 5 0.0002
550 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
551 CYSTIC FIBROSIS 1 0.0002
552 DYSPHAGIA 17 0.0002
553 MALNUTRITION 2 0.0002
554 ANGIOPATHY 1 0.0002
555 SKIN INFECTION 2 0.0002
556 MIGRAINE 17 0.0002
557 PAIN IN JAW 5 0.0002
558 MYOCARDIAL ISCHAEMIA 2 0.0002
559 DERMATITIS CONTACT 2 0.0002
560 SCAB 2 0.0002
561 MUSCULOSKELETAL DISCOMFORT 3 0.0002
562 FALL 58 0.0002
563 PARANOIA 3 0.0002
564 HOT FLUSH 13 0.0002
565 PSORIATIC ARTHROPATHY 7 0.0002
566 SPEECH DISORDER 9 0.0002
567 HYPOXIA 6 0.0002
568 DEPRESSED MOOD 9 0.0002
569 BRADYCARDIA 9 0.0002
570 BRADYKINESIA 1 0.0002
571 COVID-19 PNEUMONIA 2 0.0002
572 TACHYCARDIA 15 0.0002
573 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
574 ATAXIA 2 0.0002
575 THIRST 3 0.0002
576 COUGH 47 0.0002
577 MULTIPLE SCLEROSIS 8 0.0002
578 WRIST FRACTURE 2 0.0002
579 CHEST DISCOMFORT 17 0.0002
580 MENTAL IMPAIRMENT 4 0.0002
581 RESTLESS LEGS SYNDROME 3 0.0002
582 FIBROMYALGIA 4 0.0002
583 RESPIRATORY DEPRESSION 2 0.0002
584 INJECTION SITE RASH 5 0.0002
585 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
586 MUSCLE SPASTICITY 2 0.0002
587 SPINAL OPERATION 2 0.0002
588 TENDON RUPTURE 2 0.0002
589 GAIT DISTURBANCE 31 0.0002
590 ABNORMAL WEIGHT GAIN 2 0.0002
591 CONJUNCTIVITIS 3 0.0002
592 PHARYNGITIS 2 0.0002
593 CYST 2 0.0002
594 HEPATIC STEATOSIS 3 0.0002
595 NECK PAIN 9 0.0002
596 ILEUS 2 0.0002
597 HAIR COLOUR CHANGES 2 0.0002
598 AGEUSIA 4 0.0002
599 DRY EYE 8 0.0002
600 INJECTION SITE DISCOLOURATION 2 0.0002
601 DYSARTHRIA 6 0.0002
602 SOMNOLENCE 32 0.0002
603 CELLULITIS 8 0.0002
604 MUSCULAR WEAKNESS 18 0.0002
605 ANXIETY 45 0.0002
606 PROTEINURIA 3 0.0002
607 HAEMATEMESIS 4 0.0002
608 CARDIAC ARREST 13 0.0002
609 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
610 INJECTION SITE IRRITATION 2 0.0002
611 METABOLIC ACIDOSIS 5 0.0002
612 THROAT IRRITATION 7 0.0002
613 INTENTIONAL OVERDOSE 10 0.0002
614 ABDOMINAL PAIN UPPER 32 0.0002
615 INJECTION SITE INDURATION 2 0.0002
616 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
617 PLATELET COUNT INCREASED 2 0.0002
618 NASAL CONGESTION 9 0.0002
619 CHOLELITHIASIS 5 0.0002
620 IMPAIRED HEALING 5 0.0002
621 ANHEDONIA 4 0.0002
622 WHEEZING 9 0.0002
623 STAPHYLOCOCCAL INFECTION 5 0.0002
624 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
625 SINUS DISORDER 3 0.0002
626 CORONAVIRUS INFECTION 1 0.0002
627 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
628 INFUSION RELATED REACTION 10 0.0002
629 VIRAL INFECTION 5 0.0002
630 AGITATION 11 0.0001
631 ABORTION SPONTANEOUS 6 0.0001
632 BREAST MASS 1 0.0001
633 SUICIDE ATTEMPT 9 0.0001
634 BRONCHIECTASIS 1 0.0001
635 COLITIS ISCHAEMIC 1 0.0001
636 FREQUENT BOWEL MOVEMENTS 4 0.0001
637 THROAT TIGHTNESS 4 0.0001
638 FATIGUE 115 0.0001
639 OEDEMA 8 0.0001
640 DISCOMFORT 9 0.0001
641 NEUROPATHY PERIPHERAL 14 0.0001
642 TACHYPNOEA 2 0.0001
643 BODY TEMPERATURE INCREASED 3 0.0001
644 BACK PAIN 34 0.0001
645 HAEMOGLOBIN DECREASED 15 0.0001
646 CROHN'S DISEASE 1 0.0001
647 OSTEOPOROSIS 6 0.0001
648 RIB FRACTURE 3 0.0001
649 CORONARY ARTERY OCCLUSION 2 0.0001
650 MEMORY IMPAIRMENT 20 0.0001
651 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
652 DIABETES MELLITUS 11 0.0001
653 PROCEDURAL PAIN 4 0.0001
654 MENTAL STATUS CHANGES 4 0.0001
655 FEELING COLD 4 0.0001
656 APHONIA 2 0.0001
657 DERMATITIS 3 0.0001
658 DEMENTIA 4 0.0001
659 MASS 2 0.0001
660 WOUND 4 0.0001
661 CARPAL TUNNEL SYNDROME 2 0.0001
662 INSOMNIA 38 0.0001
663 KNEE ARTHROPLASTY 3 0.0001
664 BLISTER 8 0.0001
665 SKIN REACTION 2 0.0001
666 NASOPHARYNGITIS 26 0.0001
667 RHEUMATOID ARTHRITIS 16 0.0001
668 EATING DISORDER 3 0.0001
669 HYPERHIDROSIS 18 0.0001
670 SUBDURAL HAEMATOMA 2 0.0001
671 HYPERSOMNIA 4 0.0001
672 RHINORRHOEA 9 0.0001
673 MOBILITY DECREASED 10 0.0001
674 PARAESTHESIA ORAL 2 0.0001
675 HYPOKINESIA 2 0.0001
676 PRODUCT DISPENSING ERROR 3 0.0001
677 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
678 FLUSHING 14 0.0001
679 PANIC ATTACK 5 0.0001
680 DYSSTASIA 4 0.0001
681 BONE PAIN 8 0.0001
682 SURGERY 8 0.0001
683 DYSURIA 5 0.0001
684 PAIN IN EXTREMITY 40 0.0001
685 BLINDNESS TRANSIENT 1 0.0001
686 DRY MOUTH 11 0.0001
687 PSYCHOTIC DISORDER 4 0.0001
688 CEREBRAL DISORDER 1 0.0001
689 ARTHROPOD BITE 1 0.0001
690 TOOTH DISORDER 3 0.0001
691 IMMUNODEFICIENCY 2 0.0001
692 ORAL PAIN 3 0.0001
693 GASTROINTESTINAL DISORDER 12 0.0001
694 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
695 RESPIRATORY DISORDER 4 0.0001
696 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
697 IRRITABILITY 8 0.0001
698 CHROMATURIA 3 0.0001
699 WEIGHT DECREASED 37 0.0001
700 COLITIS 5 0.0001
701 PRODUCT AVAILABILITY ISSUE 3 0.0001
702 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
703 OEDEMA PERIPHERAL 16 0.0001
704 SKIN EXFOLIATION 11 0.0001
705 THYROID DISORDER 2 0.0001
706 DELUSION 2 0.0001
707 ARTHRITIS 10 0.0001
708 INFLUENZA 14 0.0001
709 SCIATICA 2 0.0001
710 ABSCESS 2 0.0001
711 SENSORY DISTURBANCE 2 0.0001
712 MOVEMENT DISORDER 4 0.0001
713 NIGHT SWEATS 4 0.0001
714 LOCALISED INFECTION 3 0.0001
715 CONSTIPATION 27 0.0001
716 FLATULENCE 7 0.0001
717 DYSKINESIA 5 0.0001
718 ASPHYXIA 1 0.0001
719 LETHARGY 7 0.0001
720 MANIA 2 0.0001
721 PHOTOSENSITIVITY REACTION 2 0.0001
722 OFF LABEL USE 106 0.0001
723 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
724 PAIN 74 0.0001
725 CYTOMEGALOVIRUS INFECTION 2 0.0001
726 DIZZINESS 60 0.0001
727 SKIN DISORDER 4 0.0001
728 ROAD TRAFFIC ACCIDENT 5 0.0001
729 INJECTION SITE PRURITUS 8 0.0001
730 URTICARIA 20 0.0001
731 WITHDRAWAL SYNDROME 5 0.0001
732 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
733 ANGER 4 0.0001
734 FLUID RETENTION 6 0.0001
735 BLOOD PRESSURE INCREASED 18 0.0001
736 INFECTION 17 0.0001
737 HYPOPHAGIA 3 0.0001
738 FEELING ABNORMAL 28 0.0001
739 SCAR 2 0.0001
740 CARDIAC OPERATION 1 0.0001
741 INFLAMMATION 6 0.0001
742 DIARRHOEA 75 0.0001
743 HYPOACUSIS 5 0.0001
744 BLOOD MAGNESIUM DECREASED 1 0.0001
745 EXPOSURE VIA SKIN CONTACT 3 0.0001
746 CARDIAC MURMUR 1 0.0001
747 DEVICE DEFECTIVE 2 0.0001
748 VERTIGO 7 0.0001
749 PNEUMONIA 37 0.0001
750 FEELING HOT 7 0.0001
751 BLOOD CALCIUM INCREASED 1 0.0001
752 GASTRITIS 3 0.0001
753 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
754 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
755 NAUSEA 89 0.0001
756 DECREASED APPETITE 26 0.0001
757 PULMONARY OEDEMA 5 0.0001
758 DYSPNOEA 63 0.0001
759 RASH PRURITIC 6 0.0001
760 OSTEOMYELITIS 2 0.0001
761 LIMB INJURY 3 0.0001
762 MOOD ALTERED 3 0.0001
763 SKIN DISCOLOURATION 5 0.0001
764 ANAPHYLACTIC REACTION 6 0.0001
765 OROPHARYNGEAL PAIN 10 0.0001
766 CHEST PAIN 20 0.0001
767 EYE SWELLING 4 0.0001
768 ABDOMINAL DISCOMFORT 18 0.0001
769 BACTERIAL INFECTION 2 0.0001
770 HEADACHE 67 0.0001
771 PRODUCT USE ISSUE 20 0.0001
772 VOMITING 50 0.0001
773 DYSPNOEA EXERTIONAL 4 0.0001
774 BLOOD GLUCOSE INCREASED 20 0.0001
775 INTESTINAL OBSTRUCTION 4 0.0001
776 ARTHRALGIA 44 0.0001
777 ABDOMINAL DISTENSION 11 0.0001
778 BLOOD URINE PRESENT 2 0.0001
779 GASTRIC ULCER 2 0.0001
780 PULMONARY EMBOLISM 10 0.0001
781 MUSCULOSKELETAL DISORDER 2 0.0001
782 DEHYDRATION 14 0.0001
783 EYE IRRITATION 6 0.0001
784 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
785 BLOOD GLUCOSE DECREASED 5 0.0001
786 MUSCLE SPASMS 19 0.0001
787 DYSTONIA 2 0.0001
788 HYPOGLYCAEMIA 5 0.0001
789 DRUG WITHDRAWAL SYNDROME 9 0.0001
790 ORAL HERPES 2 0.0001
791 TREMOR 17 0.0001
792 ACUTE MYOCARDIAL INFARCTION 3 0.0001
793 URINARY INCONTINENCE 3 0.0001
794 RASH 44 0.0001
795 CEREBROVASCULAR ACCIDENT 17 0.0001
796 BRAIN INJURY 1 0.0001
797 JOINT SWELLING 12 0.0001
798 LACRIMATION INCREASED 3 0.0001
799 PRODUCT PHYSICAL ISSUE 2 0.0001
800 CORONARY ARTERY DISEASE 3 0.0001
801 PRODUCT ADMINISTRATION ERROR 2 0.0001
802 PRURITUS 38 0.0001
803 ASTHENIA 37 0.0001
804 MALAISE 43 0.0001
805 INJECTION SITE WARMTH 2 0.0001
806 LIMB DISCOMFORT 3 0.0001
807 TOOTH LOSS 2 0.0001
808 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
809 BONE DENSITY DECREASED 3 0.0001
810 DRUG-INDUCED LIVER INJURY 3 0.0001
811 CHILLS 11 0.0001
812 PLATELET COUNT DECREASED 10 0.0001
813 WEIGHT INCREASED 21 0.0001
814 IRRITABLE BOWEL SYNDROME 2 0.0001
815 RECTAL HAEMORRHAGE 4 0.0001
816 CONFUSIONAL STATE 15 0.0001
817 DECREASED ACTIVITY 1 0.0001
818 SWELLING FACE 6 0.0001
819 DYSPEPSIA 9 0.0001
820 BLOOD GLUCOSE FLUCTUATION 1 0.0001
821 HOSPITALISATION 14 0.0001
822 ANGIOEDEMA 4 0.0001
823 LIVER DISORDER 4 0.0001
824 STEVENS-JOHNSON SYNDROME 2 0.0001
825 URINARY RETENTION 3 0.0001
826 DRY SKIN 12 0.0001
827 GAIT INABILITY 3 0.0001
828 RASH PAPULAR 2 0.0001
829 THERAPY NON-RESPONDER 4 0.0001
830 BLOOD CALCIUM DECREASED 1 0.0001
831 NEPHROLITHIASIS 4 0.0001
832 CARDIAC FAILURE CONGESTIVE 7 0.0001
833 HERPES ZOSTER 5 0.0001
834 THROMBOSIS 7 0.0001
835 SHOCK 2 0.0001
836 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
837 MUSCLE TWITCHING 2 0.0001
838 CAESAREAN SECTION 1 0.0001
839 RENAL DISORDER 4 0.0001
840 CONDITION AGGRAVATED 26 0.0001
841 ACUTE KIDNEY INJURY 13 0.0001
842 LYMPHADENOPATHY 3 0.0001
843 BLOOD IRON DECREASED 1 0.0001
844 PRODUCT PRESCRIBING ERROR 2 0.0001
845 CHOLECYSTITIS 1 0.0001
846 ACCIDENT 1 0.0001
847 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
848 RENAL FAILURE 11 0.0001
849 ILL-DEFINED DISORDER 5 0.0001
850 RESPIRATORY FAILURE 6 0.0001
851 DRUG INTERACTION 13 0.0001
852 INJECTION SITE URTICARIA 2 0.0001
853 INJECTION SITE PAIN 25 0.0001
854 ENCEPHALOPATHY 2 0.0001
855 INJECTION SITE MASS 3 0.0001
856 VISUAL IMPAIRMENT 10 0.0001
857 INJECTION SITE ERYTHEMA 10 0.0001
858 VISION BLURRED 11 0.0001
859 BRAIN OEDEMA 1 0.0001
860 ANAEMIA 15 0.0001
861 SKIN ULCER 2 0.0001
862 PALPITATIONS 9 0.0001
863 DEAFNESS 2 0.0001
864 ECZEMA 4 0.0001
865 BEDRIDDEN 1 0.0001
866 ANKYLOSING SPONDYLITIS 1 0.0001
867 PANCREATITIS 4 0.0001
868 INJECTION SITE BRUISING 6 0.0001
869 BREAST CANCER FEMALE 2 0.0001
870 CARDIAC DISORDER 7 0.0001
871 SWELLING 7 0.0001
872 EXTRA DOSE ADMINISTERED 3 0.0001
873 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
874 HYPOAESTHESIA 11 0.0001
875 HEPATIC ENZYME INCREASED 5 0.0001
876 AKATHISIA 1 0.0001
877 ACUTE HEPATIC FAILURE 1 0.0001
878 ERYTHEMA 15 0.0001
879 SKIN LESION 2 0.0001
880 INJECTION SITE REACTION 5 0.0001
881 DRUG INTOLERANCE 7 0.0001
882 DIVERTICULITIS 2 0.0001
883 ARTHROPATHY 4 0.0001
884 POLLAKIURIA 3 0.0001
885 CARDIO-RESPIRATORY ARREST 3 0.0001
886 SEPSIS 8 0.0001
887 HEART RATE INCREASED 7 0.0001
888 ANGINA PECTORIS 2 0.0001
889 PANCREATIC CARCINOMA 2 0.0001
890 ANOSMIA 1 0.0001
891 DRUG INEFFECTIVE 91 0.0001
892 DYSPHONIA 4 0.0001
893 LABORATORY TEST ABNORMAL 2 0.0001
894 HAEMORRHAGE 7 0.0001
895 EPISTAXIS 5 0.0001
896 BONE LOSS 1 0.0001
897 HALLUCINATION 5 0.0001
898 APHASIA 2 0.0001
899 HYPERTENSION 14 0.0001
900 UNEVALUABLE EVENT 5 0.0001
901 EMOTIONAL DISTRESS 8 0.0001
902 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
903 EPILEPSY 2 0.0001
904 INJECTION SITE SWELLING 5 0.0001
905 TOXICITY TO VARIOUS AGENTS 11 0.0001
906 HYPERSENSITIVITY 12 0.0001
907 FEMUR FRACTURE 2 0.0001
908 BASAL CELL CARCINOMA 1 0.0001
909 NERVOUS SYSTEM DISORDER 2 0.0001
910 PYREXIA 22 0.0001
911 PARAESTHESIA 10 0.0001
912 OCULAR HYPERAEMIA 3 0.0001
913 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
914 RASH ERYTHEMATOUS 3 0.0001
915 MOOD SWINGS 2 0.0001
916 CARDIAC FAILURE 5 0.0001
917 INCORRECT DOSE ADMINISTERED 14 0.0001
918 PSORIASIS 8 0.0001
919 EYE DISORDER 2 0.0001
920 DRUG ABUSE 5 0.0001
921 COAGULOPATHY 1 0.0001
922 AGGRESSION 3 0.0001
923 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
924 EYE PRURITUS 2 0.0001
925 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
926 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
927 GASTRIC DISORDER 2 0.0001
928 DELIRIUM 2 0.0001
929 NERVOUSNESS 3 0.0001
930 MYOCARDIAL INFARCTION 10 0.0001
931 MUSCULOSKELETAL PAIN 3 0.0001
932 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
933 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
934 UNDERDOSE 4 0.0001
935 AGRANULOCYTOSIS 1 0.0001
936 ACUTE RESPIRATORY FAILURE 1 0.0001
937 ATRIAL FIBRILLATION 5 0.0001
938 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
939 DISORIENTATION 2 0.0001
940 PLEURAL EFFUSION 3 0.0000
941 BONE MARROW FAILURE 1 0.0000
942 BLINDNESS 2 0.0000
943 RHABDOMYOLYSIS 2 0.0000
944 AMNESIA 3 0.0000
945 DEVICE DISLOCATION 2 0.0000
946 SEPTIC SHOCK 2 0.0000
947 PRODUCT DOSE OMISSION 3 0.0000
948 MUSCULOSKELETAL STIFFNESS 4 0.0000
949 ADVERSE DRUG REACTION 4 0.0000
950 SKIN IRRITATION 2 0.0000
951 TINNITUS 2 0.0000
952 INJURY 3 0.0000
953 DISEASE RECURRENCE 2 0.0000
954 SKIN BURNING SENSATION 3 0.0000
955 OVERDOSE 9 0.0000
956 LUNG DISORDER 2 0.0000
957 ACNE 3 0.0000
958 ABDOMINAL PAIN LOWER 1 0.0000
959 CHRONIC KIDNEY DISEASE 3 0.0000
960 THERAPY CESSATION 2 0.0000
961 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
962 NO ADVERSE EVENT 7 0.0000
963 DEATH 32 0.0000
964 TREATMENT NONCOMPLIANCE 2 0.0000
965 HAEMATOCHEZIA 2 0.0000
966 ALOPECIA 7 0.0000
967 HYPONATRAEMIA 2 0.0000
968 PRODUCT SUBSTITUTION ISSUE 2 0.0000
969 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
970 ASCITES 1 0.0000
971 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
972 DEEP VEIN THROMBOSIS 2 0.0000
973 NEOPLASM MALIGNANT 2 0.0000
974 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
975 CEREBRAL HAEMORRHAGE 1 0.0000
976 ABNORMAL BEHAVIOUR 1 0.0000
977 TREATMENT FAILURE 2 0.0000
978 PRODUCT STORAGE ERROR 2 0.0000
979 INTENTIONAL PRODUCT MISUSE 2 0.0000
980 DEVICE ISSUE 2 0.0000
981 NEUTROPENIA 3 0.0000
982 ADVERSE EVENT 2 0.0000
983 BREAST CANCER 2 0.0000
984 ARRHYTHMIA 1 0.0000
985 DRUG DEPENDENCE 3 0.0000
986 DRUG DOSE OMISSION 3 0.0000
987 CONVULSION 1 0.0000
988 BURNING SENSATION 1 0.0000